The Radboud Biobank has added one new sub-biobank to the collection: HEMLYM.
The Hematology-Lymphoma Biobank plans to collect blood, saliva, serum and cell-free DNA from every lymphoma patient, in addition to the residual material available from the Pathology department (tumor tissue), the Hematology department and the Laboratory of Hematology (bone marrow, peripheral blood and tumor tissue). In recent years, much progress has been made in the knowledge surrounding the processes involved in the development and progression of lymph node cancer and the response to therapy. The aim and ambition of HEMLYM is to improve the diagnosis and treatment of patients with lymphoma.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Costs for internal researchers in case of request for samples26 May 2020
As of January 1, 2020, internal researchers who request samples from the Radboud Biobank will only be charged for the number of samples received.read more